Cargando…

A chemoresistance lncRNA signature for recurrence risk stratification of colon cancer patients with chemotherapy

Chemotherapy is considered the nonsurgical treatment of choice for colon cancer patients. However, no precise molecular markers are available to determine which patients can actually benefit from it. In this study, we identified 55 chemotherapy-specific long non-coding RNAs (lncRNAs) of colon cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hao, Gao, Yuzhen, Vafaei, Somayeh, Yu, Qiaoyan, Zhang, Jun, Wang, Liangjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733234/ https://www.ncbi.nlm.nih.gov/pubmed/35036055 http://dx.doi.org/10.1016/j.omtn.2021.12.015

Ejemplares similares

Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer
por: Lin, Yaobin, et al.
Publicado: (2022)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
por: Chen, Lu, et al.
Publicado: (2023)

Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer
por: Zhang, Zeyu, et al.
Publicado: (2022)

Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
por: Ahmadpour, Seyedeh Tayebeh, et al.
Publicado: (2023)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
por: Zeng, Ying, et al.
Publicado: (2019)

Stratification of lncRNA modulation networks in breast cancer
por: Yu, Wen-Hsuan, et al.
Publicado: (2022)

Diabetes regulated anti-inflammatory lncRNA is overexpressed in triple-negative breast cancer and predicts chemoresistance and tumor recurrence
por: Wang, Peng, et al.
Publicado: (2022)

Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

Identification and Analysis of An Epigenetically Regulated Five-lncRNA Signature Associated With Outcome and Chemotherapy Response in Ovarian Cancer
por: Yang, Hao, et al.
Publicado: (2021)

Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
por: Qin, Shuang, et al.
Publicado: (2023)

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Chi, et al.
Publicado: (2022)

Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
por: Gao, Yuzhen, et al.
Publicado: (2020)

Comprehensive analyses of correlation and survival reveal informative lncRNA prognostic signatures in colon cancer
por: Gao, Meihong, et al.
Publicado: (2021)

Identification and Validation of an Endoplasmic Reticulum Stress-Related lncRNA Signature for Colon Adenocarcinoma Patients
por: Chen, Xueru, et al.
Publicado: (2022)

Erratum: Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer
por: Qu, Ailin, et al.
Publicado: (2023)

Prediction of Recurrence in Cervical Cancer Using a Nine-lncRNA Signature
por: Mao, Yu, et al.
Publicado: (2019)

Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
por: Chen, Pan, et al.
Publicado: (2023)

Integrative learning in developing an immunologic lncRNA signature as a consensus risk-stratification tool for lung adenocarcinoma
por: Chen, Zijian, et al.
Publicado: (2023)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer
por: Luo, Jian, et al.
Publicado: (2022)

A stroma‐related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early‐stage colon cancer
por: Zhou, Rui, et al.
Publicado: (2020)

The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Yang, Haixiu, et al.
Publicado: (2017)

A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas
por: Cheng, Sen, et al.
Publicado: (2021)

A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer
por: Chen, Qiang, et al.
Publicado: (2021)

Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma
por: Fu, Yi, et al.
Publicado: (2021)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2018)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022)

Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer
por: Zhu, Liyuan, et al.
Publicado: (2019)

LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5
por: Xia, Chongsheng, et al.
Publicado: (2022)

Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer
por: Lin, Yilin, et al.
Publicado: (2020)

Identification of a Four-lncRNA Prognostic Signature for Colon Cancer Based on Genome Instability
por: Yun, Duo, et al.
Publicado: (2021)

Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer
por: Yin, Tengfei, et al.
Publicado: (2021)

A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
por: Li, Dongming, et al.
Publicado: (2023)

LncRNA AWPPH overexpression predicts the recurrence of periodontitis
por: Wang, Xiaofang, et al.
Publicado: (2019)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

A seven-lncRNA signature for predicting Ewing’s sarcoma
por: Chen, Zhihui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uvncs7klq9q8esnmtboun3en5t